# Adaptive Digital Twin Framework for Cancer Drug Response Prediction

Overview

This repository contains the implementation of an adaptive digital twin framework developed for the prediction of cancer drug response. The work explores how patient-specific representations can be constructed from molecular and clinical features, and how these representations can be used within a machine learning framework to model treatment outcomes.

The study follows a two-stage progression:

Version 1.0: a minimal proof-of-concept using a small cohort
Version 2.0: an expanded framework utilizing a synthetically generated dataset to enable systematic evaluation

The primary objective is methodological: to investigate the integration of data augmentation, predictive modeling, and interpretability within a unified digital twin paradigm.

# Repository Structure


├── data/                 # datasets used for model development and evaluation

├── version_1_scripts/           

├── version_2_scripts/           

├── mainscripts/           # notebooks

├── results/              # Output metrics, figures, and evaluation summaries

├── tables/               # Trained model performances 

└── README.md

# Methodological Summary
Data Generation and Augmentation

A synthetic dataset was constructed to address the limitations of small sample size. The augmentation pipeline includes:

stochastic perturbation of gene expression values
controlled feature scaling to simulate biological variability
multivariate sampling to preserve feature correlations
hybrid profile generation via feature aggregation

The final dataset comprises approximately 2,000 patient profiles across multiple cancer categories, with associated clinical variables and response labels.

Predictive Modeling

Drug response is formulated as a binary classification task. The primary model is a Random Forest classifier, selected for its balance between representational capacity and interpretability.

Baseline models include:

logistic regression
support vector machines
gradient boosting
multi-layer perceptron

Evaluation is performed using stratified cross-validation, with performance assessed via accuracy, AUC-ROC, F1-score, sensitivity, and specificity.

Confidence Estimation

Each prediction is accompanied by a confidence score derived from model output probabilities. This enables stratification of predictions based on relative certainty within the model’s output space.

Interpretability

Model interpretability is addressed through:

feature importance analysis
conditional response behavior (partial dependence)
similarity-based reasoning between patient profiles

These components provide insight into how model outputs are generated within the constructed dataset.

Results (Summary)
Predictive performance comparable to baseline models
Highest AUC achieved by the Random Forest–based digital twin
Strong separation between high-confidence and low-confidence predictions within the evaluation framework

All results should be interpreted within the context of a synthetic dataset.

Limitations
The dataset is fully synthetic and derived from a minimal initial cohort
No external validation on real-world clinical data
Simplified representation of treatment response (binary classification)
No temporal or longitudinal modeling

Accordingly, the framework should be viewed as a methodological exploration rather than a clinically validated system.
